Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin, Science, vol.307, issue.5708, pp.426-430, 2005. ,
DOI : 10.1126/science.1097243
Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: A contradictory piece of the puzzle, Nutrition, vol.26, issue.11-12, pp.1130-1133, 2010. ,
DOI : 10.1016/j.nut.2008.11.019
Increased plasma visfatin levels in subjects with the metabolic syndrome, European Journal of Clinical Investigation, vol.115, issue.1, pp.71-72, 2008. ,
DOI : 10.1111/j.1365-2362.2007.01904.x
Visfatin, glucose metabolism and vascular disease: a review of evidence, Diabetology & Metabolic Syndrome, vol.2, issue.1, p.21, 2010. ,
DOI : 10.1186/1758-5996-2-21
Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans, Diabetologia, vol.3, issue.5, pp.1200-1211, 2011. ,
DOI : 10.1007/s00125-010-2042-z
Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile, Nutrition, Metabolism and Cardiovascular Diseases, vol.23, issue.4, pp.330-336, 2013. ,
DOI : 10.1016/j.numecd.2011.07.002
Expression and Regulation of Nampt in Human Islets, PLoS ONE, vol.318, issue.3, p.58767, 2013. ,
DOI : 10.1371/journal.pone.0058767.t002
Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine, Clinical Science, vol.115, issue.1, pp.13-23, 2008. ,
DOI : 10.1042/CS20070226
Pre???B cell colony???enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis, Journal of Clinical Investigation, vol.113, issue.9, pp.1318-1327, 2004. ,
DOI : 10.1172/JCI19930
Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis, Clinical Endocrinology, vol.54, issue.6, pp.878-884, 2008. ,
DOI : 10.1111/j.1365-2265.2008.03248.x
Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans, Clinical Endocrinology, vol.22, issue.2, pp.202-207, 2009. ,
DOI : 10.1111/j.1365-2265.2008.03453.x
Factors of Insulin Resistance Syndrome-Related Phenotypes Are Linked to Genetic Locations on Chromosomes 6 and 7 in Nondiabetic Mexican-Americans, Diabetes, vol.51, issue.3, pp.841-847, 2002. ,
DOI : 10.2337/diabetes.51.3.841
A Visfatin Promoter Polymorphism Is Associated with Low-Grade Inflammation and Type 2 Diabetes*, Obesity, vol.70, issue.12, pp.2119-2126, 2006. ,
DOI : 10.1038/oby.2006.247
Common Polymorphisms in the Promoter of the Visfatin Gene (PBEF1) Influence Plasma Insulin Levels in a French-Canadian Population, Diabetes, vol.55, issue.10, pp.2896-2902, 2006. ,
DOI : 10.2337/db06-0189
) and Its Relation to Glucose Metabolism and Fat-Depot-Specific Messenger Ribonucleic Acid Expression in Humans, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.7, pp.2725-2731, 2006. ,
DOI : 10.1210/jc.2006-0149
Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects, Journal of Diabetes and its Complications, vol.26, issue.2, pp.94-98, 2012. ,
DOI : 10.1016/j.jdiacomp.2012.02.008
Color and Genomic Ancestry in Brazilians: A Study with Forensic Microsatellites, Human Heredity, vol.62, issue.4, pp.190-195, 2006. ,
DOI : 10.1159/000096872
Interaction Between Poor Glycemic Control and 9p21 Locus on Risk of Coronary Artery Disease in Type 2 Diabetes, JAMA, vol.300, issue.20, pp.2389-2397, 2008. ,
DOI : 10.1001/jama.2008.649
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation, Annals of Internal Medicine, vol.130, issue.6, pp.461-470, 1999. ,
DOI : 10.7326/0003-4819-130-6-199903160-00002
Serum levels of vaspin and visfatin in patients with coronary artery disease???Kozani study, Clinica Chimica Acta, vol.412, issue.1-2, pp.48-52, 2011. ,
DOI : 10.1016/j.cca.2010.09.012
Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease, European Journal of Endocrinology, vol.158, issue.2, pp.203-207, 2008. ,
DOI : 10.1530/EJE-07-0633
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review, Diabetes/Metabolism Research and Reviews, vol.382, issue.1-2, pp.515-527, 2011. ,
DOI : 10.1002/dmrr.1201
Visfatin in adipocytes is upregulated by hypoxia through HIF1??-dependent mechanism, Biochemical and Biophysical Research Communications, vol.349, issue.3, pp.875-882, 2006. ,
DOI : 10.1016/j.bbrc.2006.07.083
-induced myocardial apoptosis: A missing link between obesity and cardiovascular disease, Journal of Cellular Physiology, vol.4, issue.3, pp.495-501, 2013. ,
DOI : 10.1002/jcp.24257
URL : https://hal.archives-ouvertes.fr/hal-00908887
The novel adipocytokine visfatin exerts direct cardioprotective effects, Journal of Cellular and Molecular Medicine, vol.115, issue.4, pp.1395-1403, 2008. ,
DOI : 10.1111/j.1582-4934.2008.00332.x
The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion, Journal of Molecular and Cellular Cardiology, vol.35, issue.4, pp.339-341, 2003. ,
DOI : 10.1016/S0022-2828(03)00043-9
Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis: Possible Role in Inflammation and Plaque Destabilization, Circulation, vol.115, issue.8, pp.972-980, 2007. ,
DOI : 10.1161/CIRCULATIONAHA.106.665893
Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: Role in visfatin-induced angiogenesis, Atherosclerosis, vol.205, issue.1, pp.113-119, 2009. ,
DOI : 10.1016/j.atherosclerosis.2008.11.024
The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells, Thrombosis Research, vol.130, issue.3, pp.403-408, 2012. ,
DOI : 10.1016/j.thromres.2012.06.007
Visfatin/NAMPT: A Multifaceted Molecule with Diverse Roles in Physiology and Pathophysiology, Annual Review of Nutrition, vol.32, issue.1, pp.229-243, 2012. ,
DOI : 10.1146/annurev-nutr-071811-150746
Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2, Biochemical and Biophysical Research Communications, vol.357, issue.1, pp.150-156, 2007. ,
DOI : 10.1016/j.bbrc.2007.03.105
Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.6, pp.2563-2568, 2004. ,
DOI : 10.1210/jc.2004-0518
Adiponectin down-regulates acyl-coenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages, Biochemical and Biophysical Research Communications, vol.317, issue.3, pp.831-836, 2004. ,
DOI : 10.1016/j.bbrc.2004.03.123
Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages, Circulation, vol.103, issue.8, pp.1057-1063, 2001. ,
DOI : 10.1161/01.CIR.103.8.1057
Nampt/PBEF/Visfatin Regulates Insulin Secretion in ?? Cells as a Systemic NAD Biosynthetic Enzyme, Cell Metabolism, vol.6, issue.5, pp.363-375, 2007. ,
DOI : 10.1016/j.cmet.2007.09.003
Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis, Science, vol.324, issue.5927, pp.651-654, 2009. ,
DOI : 10.1126/science.1171641
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738420
A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease, Molecular Biology Reports, vol.33, issue.1, pp.819-825, 2011. ,
DOI : 10.1007/s11033-010-0171-6
NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction, Clinica Chimica Acta, vol.413, issue.7-8, pp.727-732, 2012. ,
DOI : 10.1016/j.cca.2012.01.002
Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis, Clin Exp Rheumatol, vol.29, pp.681-688, 2011. ,
Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects, Cardiovascular Diabetology, vol.12, issue.1 ,
DOI : 10.1016/j.cca.2012.01.002
URL : https://hal.archives-ouvertes.fr/inserm-00868742